Podcasts about Cancer vaccine

What if the cancer diagnosis your doctor gave you is technically correct — but the treatment they chose has almost nothing to do with your actual cancer?This week, I sat down with Ed Clay, co-founder of TAM Center and Stem Cells, one of the world's most advanced translational medicine hospitals in Tijuana, Mexico. Ed started this journey the way most great things do — out of love. His mom got sick with no options in the US, so he bought a hospital and hired back the staff. She came in in a wheelchair and walked out.But what Ed has built since then? That's what blew my mind. His team — including the former chief of infectious disease at the NIH and the scientist who invented a test that reads 10,000 proteins at once — can sequence 20,000 of your cancer genes. Most US oncologists test 90.He dropped a bomb: there is not a single product on the market right now that can accurately detect cancer early through a blood test. Companies claiming otherwise? He's read their data. It's four patients.He also revealed why two people with the exact same cancer diagnosis can need completely different treatments — and why that distinction could be the difference between responding and not.This conversation will change how you think about what cancer actually is, and what it means to actually fight it.What we talk about:Why "ovarian cancer" in two different women can be two completely different diseases at the genetic levelThe lie behind liquid biopsy tests claiming to detect cancer in your bloodHow TAM goes from discovery to treating a patient in 6–12 months instead of 7 yearsA UFC champion's sister went from "weeks to live" to cancer-free in two months — here's what they foundZombie cells, senescence, and the peptide vaccine that could be the actual fountain of youthWhy combining genomics, proteomics, and methylation data could unlock cures for almost everythingCoffee enemas, Gerson therapy, and what happens to your body on day threeEpisode Links & Resources:Website: The Tam Center - https://thetamcenter.com | CPI Stem Cells - https://cellularperformanceinstitute.com/Podcast: https://www.edclayshow.com/Instagram: https://www.instagram.com/edclayofficialConnect with Tracy:Website: ⁠https://tracyduhs.com/⁠Hydration Shop: ⁠https://sanctuarysd.com/⁠Instagram: ⁠@tracyduhs⁠Flow FAM Community: ⁠https://tracyduhs.com/join-flow-fam/⁠

Welcome to the Veterinary Breakroom! Join Alyssa Watson, DVM, and Beth Molleson, DVM, as they discuss a case out of Australia—where an owner helped drive development of an mRNA vaccine for their dog's mast cell disease—that has sparked big questions in the exam room. In this episode, they unpack the implications for clinical practice, client expectations, and how veterinarians can navigate conversations around emerging, highly personalized therapies. Brought to you by Zoetis Resources: https://news.unsw.edu.au/en/meet-the-man-who-designed-a-cancer-vaccine-for-his-dog https://www.zoetisus.com/petcare/care-is-your-calling/ Contact: podcast@instinct.vet Where To Find Us: Website: CliniciansBrief.com/Podcasts YouTube: Youtube.com/@clinicians_brief Facebook: Facebook.com/CliniciansBrief LinkedIn: LinkedIn.com/showcase/CliniciansBrief/ Instagram: @Clinicians.Brief X: @CliniciansBrief The Team: Alyssa Watson, DVM - Host Beth Molleson, DVM - Host Alexis Ussery - Producer & Multimedia Specialist Disclaimer: This podcast recording represents the opinions of Dr. Alyssa Watson and Dr. Beth Molleson. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.

Headlines:  – Welcome To Mo News (02:00) – Iran Ceasefire Countdown As Latest Pakistan Talks Look Iffy (07:10) – Energy Secretary Says Gas Prices May Stay Above $3 A Gallon Until 2027 (14:00) – A Look At The Democrat-Israel Divorce (15:00) – Apple Names John Ternus CEO, Replacing Tim Cook, Who Becomes Chairman (26:50) – Trump Labor Secretary Resigns Amid Scandal (30:00) – FBI Director Sues The Atlantic For $250 Million Over Story On Alleged Excessive Drinking (33:00) – As Measles Takes Toll on Kids, Anti-Vaxxers Have Change of Heart (38:10) – Pancreatic Cancer mRNA Vaccine Shows Lasting Results In Early Trial (41:00) – Back To Back Boston Marathon Winners (43:00) – Humanoid Robot Wins Half-Marathon and Smashes Humans' Record (44:10) – On This Day In History (47:10) Thanks To Our Sponsors:  – ⁠Boll & Branch⁠ – 15% off first order, plus free shipping | Code: MONEWS –⁠ Industrious⁠ - Coworking office. 50% off day pass | Code: MONEWS50 – Incogni - 60% off an annual plan| Code: MONEWS – Monarch - 50% off your first year | Code: MONEWS – Factor - 50% off your first box | Code: monews50off – ShipStation - Try for free for 60 days | Code: MONEWS – Shopify – $1 per-month trial | Code: MONEWS – LMNT | Free Sample Pack with any LMNT drink mix or 12oz cans purchase – Aura Frames | $25 dollars off the Carver Mat frame | Code: MONEWS

The US military fires on and seizes an Iranian ship. Eight children were killed in the worst mass shooting in the country, since 2024.  President Trump announces an Oval Office Bible reading, amid a feud with the Pope. Promising new data from a pancreatic cancer vaccine trial. Plus, a hot air balloon makes an emergency landing in a backyard. Learn more about your ad choices. Visit podcastchoices.com/adchoices

How much do you love your dog? Well, our next story is about a Sydney man who's definitely in the running to be dog-dad of the year. Back in 2024, Paul Conyngham found out his dog Rosie had cancer. When traditional treatment routes weren't working ... being a tech guy, he turned to Artificial Intelligence and some very smart people for help. Chat GPT advised him to look into immunotherapy and was told that the University of New South Wales Ramaciotti Center for Genomics might be able to help. And help they did Paul was able to get Rosie's genomic sequencing. From there he was able to dig into the DNA data and identify a potential treatment. After a setback with a drugmaker, a team at the university developed a world-first personalised cancer treatment for Rosie. While not completely cured, her health is now doing much better and crucially for Paul, she has more time. To tell Emile more about the exciting science behind this medicine is Professor Martin Smith, Director of the Ramaciotti Centre for Genomics.

A tech entrepreneur with no biology background used ChatGPT, AlphaFold, and Grok to design a cancer vaccine for his dog (tumor shrank 75%), Pokemon Go players unknowingly generated 30 billion images now used to train delivery robots, and 4D Gaussian splats are streaming in real time in your browser.00:00 Introduction01:50 AI-Designed Cancer Vaccine for a Dog23:29 Pokemon Go Secretly Trained AI Robots44:03 4D Gaussian Splats Streaming in BrowserPowered by Dell Pro Precision : https://creatorfolio.co/badxstudiohttps://creatorfolio.co/badxstudio3

On today's Good Day Health Show - ON DEMAND…Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken begin with a medical success story with a new cancer vaccine, the importance of a strong immune system, and how we are inadvertently aging ourselves faster. Next, Doug and Dr. Ken address an increase in life expectancy, a study showing night owls have a higher risk of heart disease than early birds, and the state of public health (specifically where we're at with measles outbreaks. Moving on, Dr. Ken breaks down how weight-loss drugs are being shown to have a positive effect on heart-health when helping with weight loss. Continuing on with the discussion on heart-health and optimal cardiovascular awareness, Doug and Dr. Ken discuss what the numbers of blood pressure mean and why spikes happen at various times. Then, Doug and Dr. Ken address listener questions with a strong focus on the MIT Smart Pill, a biodegradable antenna that transmits a wireless signal from the stomach to confirm medication has been swallowed. Designed to improve adherence for high-risk patients, the pill uses zinc and cellulose materials to safely dissolve within a week, leaving only a tiny, non-biodegradable RFID chip that is naturally excreted. Website: GoodDayHealthrShow.com Social Media: @GoodDayNetworks

Intel's (INTC) recent rally isn't the only one investors should pay attention to, says Diane King Hall. She points to Moderna (MRNA) hitting a 52-week high after a trial drug to treat melanoma posted positive results. On the earnings front, Diane explains why investors are shaking off Procter & Gamble's (PG) mixed earnings and Abbott's (ABT) post-earnings sell-off. ======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some fascinating breakthroughs and regulatory updates that are shaping the future of healthcare.Starting with a pivotal advancement in Alzheimer's research, a new drug has shown promising results in slowing cognitive decline in patients with early-stage Alzheimer's disease. This innovative therapy targets amyloid plaques in the brain, which are believed to play a central role in the progression of Alzheimer's. Recent clinical trials have demonstrated that patients receiving this treatment experienced a significant reduction in the rate of cognitive deterioration compared to those on a placebo. The implications of this development are profound, offering hope for millions affected by this debilitating condition. As researchers continue to unravel the mysteries of Alzheimer's, this breakthrough marks a crucial step forward in understanding and potentially halting disease progression.Moving on to regulatory news, the FDA has recently granted accelerated approval to a novel gene therapy for a rare genetic disorder known as spinal muscular atrophy (SMA). This condition, which affects motor neurons and leads to muscle wasting and weakness, primarily impacts infants and young children. The newly approved therapy works by delivering a functional copy of the defective gene directly into the patient's cells. Early trials have shown remarkable improvements in motor function and survival rates among treated infants. This approval represents not only a lifeline for affected families but also underscores the growing potential of gene therapies to address previously untreatable genetic diseases.In another significant development, researchers have unveiled a groundbreaking study on an experimental cancer vaccine that has demonstrated efficacy in preventing tumor growth in preclinical models. Unlike traditional vaccines aimed at infectious diseases, this cancer vaccine is designed to harness the body's immune system to specifically target and destroy cancer cells. The study's results indicate that the vaccine was successful in generating a robust immune response, which significantly inhibited tumor progression. If these findings can be replicated in human trials, it could open new avenues for cancer prevention and treatment, particularly for cancers with limited therapeutic options.Shifting our focus to trends within the industry, there's an increasing emphasis on personalized medicine, reflecting a broader shift towards treatments tailored to individual patients' genetic profiles. This approach aims to optimize therapeutic efficacy while minimizing adverse effects by considering each patient's unique genetic makeup. Advances in genomic sequencing technologies and bioinformatics are driving this transformation, enabling more precise diagnostics and targeted therapies. As personalized medicine continues to evolve, it holds the promise of revolutionizing how diseases are treated and managed in clinical practice.On the topic of drug approvals, a new oral medication for type 2 diabetes has received regulatory clearance after demonstrating superior glycemic control compared to existing treatments. This drug belongs to a novel class of medications that enhance insulin sensitivity and reduce glucose production by targeting specific metabolic pathways. Clinical trials indicated significant improvements in blood sugar levels and overall metabolic health among participants. Given the global prevalence of type 2 diabetes and its associated health complications, such advancements are crucial for improving patient outcomes and reducing healthcare burdens.Lastly, focusing on collaborations within the industry, several prominent pharmaceutical companies have announced partnerships aimed at accelerating research in infectious diseases.Support the show

TWiV discusses the impact of vaccinating with Gardasil-9 adult women who are human papillomavirus positive or with confirmed squamous intraepithelial lesions, and human monoclonal antibodies that target the monkeypox virus A35 protein which protect against lethal disease. Hosts: Vincent Racaniello, Alan Dove, Rich Condit, Kathy Spindler, and Brianne Barker Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV Immune 100 live at the Incubator Long tailed macaques are now officially endangered (Science) Iceland now has mosquitoes (npr) Impact of Gardasil-9 on adult women who are HPV+ or SIL+ (Viruses) Human mAbs that protect against mpox disease (Cell) Timestamps by Jolene Ramsey. Thanks! Weekly Picks Brianne – Civet coffee: The real chemistry behind this bizarre luxury drink Kathy – Astronomy photographer of the year awards Rich – Katherine Swan Ginsburg Humanism in Medicine Program Alan – Parasitic worms can use static electricity to latch onto flies midair Vincent – How to get the best night's sleep: what the science says Listener Pick Bradon – Elevated Access Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

With more and more new research coming out on cancer treatments, it seems that we're bound to have some sort of breakthrough soon. Today Dr. Jonathan Karp and student producer Kaya Basatemur discuss an article that might just be one of the newest and best concepts that we have right now for advancement of cancer treatment. This article was published on October 9th, 2025, in the Cell Reports Medicine journal; since its publication it has become very well-discussed and brought up in the press. So what is this "cancer vaccine"? Does it work for all types of cancer? Is this a viable concept to continue researching in hopes of a cure for cancer? Tune in to this week's episode of Health 411 to find out!

Topics discussed on today's show: National Teddy Bear Day, Best Way To Get Rid Of A Body, Birthdays, History Quiz, Geographic Tongue, Cini Minis, Worst Scare of your Life, Ice, Drunk Raccoon, Spit Takes, Sports News, Super Tramp, Cancer Vaccine, Clock Botching, Worse Mistakes At Work, and Apologies.

French Prime Minister Bayrou is ousted in a no-confidence vote, Japan's Prime Minister Shigeru Ishiba resigns, The opposition wins Buenos Aires' legislative election, Six are killed in a shooting at Jerusalem bus stop, 890 people are arrested in the U.K. at a pro-Palestine protest,  Boko Haram kills over 60 in a Nigeria village attack, The U.S. Supreme Court allows the LA immigration raids to resume, The U.S. will send 300 Hyundai workers back to South Korea, A judge blocks the Trump Admin's ending of Venezuelan and Haitian temporary protected status, Erin Patterson is sentenced to life in the Australian mushroom murder trial, and Russia's cancer vaccine shows 100% efficacy in clinical trials. Sources: www.verity.news

This weeks Fear Of Missing Out report covers good Pro-life news out of Scotland. Here in the states, high school boys are being punished for not wanting girls in thier lockeroom. States are giveing illegal ailiens CDLs and it is deadly. There looks to be a new vaccine that helps against cancer and Target if feeling the Go Woke Go Broke effect. Lastly we give tribute to Dr. James Dobson and look back at his life and inpact.

Emile Donovan speaks to Professor Bev Lawton ONZM, the founder and director of the National Centre for Women's Health Research Aotearoa, and the 2025 New Zealander of the Year.

PATREON: https://www.patreon.com/blackstreetboysDISCORD: https://discord.gg/UTnCxNBDTVTWITCH: https://www.twitch.tv/bsbliveUse code "BSBPOD" for 10% any KickBuilds Lego shoe set SITEWIDE!: https://kickbuilds.com/TWITCH:BSB: https://www.twitch.tv/bsbliveBrandon: https://www.Twitch.tv/RangeBrothaRob: https://www.twitch.tv/budabearrPATREON: https://www.patreon.com/blackstreetboysDISCORD: https://discord.gg/UTnCxNBDTVApple Podcasts: https://podcasts.apple.com/us/podcast/blackstreet-boys-podcast-

"Ripped From The Headlines" is a new series for Breaking the Code, where Sonika and Gabe react to a news story with a medical anthropology lens. On this edition, they react to Anixa Biosciences' breast cancer vaccine completing phase one of clinical testing. The notion of a cancer vaccine sparked a variety of conversation topics from women's health to vaccine culture. If you love to listen to rich, fast-evolving conversations, then give this a listen and let us know what you think!Follow us on LinkedIn

Thanks to our Partners, NAPA TRACS, and Today's Class This episode features Brakes for Breasts co-founders Leigh Anne Best and Laura Frank, along with Cleveland Clinic researcher Dr. Justin Johnson, as they celebrate the automotive industry's role in raising over $2 million for breast cancer vaccine research. They share the initiative's grassroots beginnings, its 100% donation to research model, and provide an update on the vaccine's progress, highlighting the completion of Phase One trials and the upcoming launch of Phase Two. A key highlight of the campaign: During October, independent auto repair shops across the U.S. offer free brake pads to customers. For every brake service performed, the customer receives their brake pads at no cost and only pays for labor and other parts. In turn, each participating shop donates 10% of the brake service total to the Cleveland Clinic Breast Cancer Vaccine Research Fund. The episode also shares the inspiring story of Jennifer Davis, the first vaccine recipient, and encourages more shops to get involved in this unique, community driven fundraising effort that's helping fuel groundbreaking research. Show Notes: Watch Full Video Episode The First Breast Cancer Vaccine Trial Recipient: Jennifer Davis [CC 111]: https://remarkableresults.biz/remarkable-results-radio-podcast/cc111/ Introduction (00:00:00) Celebrating the $2 Million Milestone (00:03:08) Origin Story of Breaks for Breasts (00:03:46) Connection to Cleveland Clinic and Dr. Tuohy (00:06:01) Personal Motivations for Founding (00:06:55) Industry Call to Action and Broader Impact (00:07:31) Expanding Research Beyond Breast Cancer (00:10:09) Clinical Trials Overview: Phase One (00:12:14) Clinical Trials: Phase Two and Three Plans (00:14:08) How Research Funding Works at Cleveland Clinic (00:19:42) 2024 Check Presentation and Fundraising Impact (00:21:03) Jennifer Davis: The First Clinical Trial Patient (00:23:38) Hope and Realistic Expectations...

Why does cold water take your breath away? And why is it cold when you leave the cold water? What smells does an ant produce? Is there a psychological aspect to cramp? Are there any new asthma treatments in the pipeline? Are people getting vaccinated against cancer? Dr Chris Smith and Clarence Ford have all the answers... Like this podcast? Please help us by supporting the Naked Scientists

Why does cold water take your breath away? And why is it cold when you leave the cold water? What smells does an ant produce? Is there a psychological aspect to cramp? Are there any new asthma treatments in the pipeline? Are people getting vaccinated against cancer? Dr Chris Smith and Clarence Ford have all the answers... Like this podcast? Please help us by supporting the Naked Scientists

Dr Bill Nelson speaks with Dr Elizabeth Jaffee about her research in cancer vaccines, immunotherapy, and the importance of federal funding in continuing to achieve breakthroughs in cancer treatment.

Greenwich Lifesciences (GLSI) is a company that focuses on preventing the recurrence of breast cancer after surgery. CEO Dr. Snehal Patel discusses how it can create a vaccine to help the immune system kill cancerous cells in tandem with other traditional treatments. “In our Phase 2 trial we prevented 80% or more” recurrences, he claims. They are currently running a Phase 3 trial, and he discusses recruiting patients around the world.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Brian Flesner, DVM, MS, DACVIM (Oncology), discusses the recently opened clinical trial studying an Autologous Cancer Vaccine with Checkpoint Inhibitor for the Treatment of Canine Osteosarcoma.The purpose of this study is to evaluate the safety and efficacy of K9-ACV, an autologous killed tumor cell vaccine combined with a novel checkpoint inhibitor (CD200AR-L), compared to standard-of-care chemotherapy for the treatment of canine appendicular osteosarcoma (OSA). K9-ACV has safely been used in over 1,000 dogs, and the vaccine has been shown to display safety in a previous study (without the addition of the checkpoint inhibitor). By evaluating K9-ACV, this trial aims to advance safer, immune-based treatment options for canine cancer that may offer comparable or superior outcomes to chemotherapy.Find more information about this study:https://studypages.com/s/autologous-cancer-vaccine-with-checkpoint-inhibitor-for-treatment-of-canine-osteosarcoma-565406/Adrienne Wright, adrienne@ardentanimalhealth.com, +1 (859) 619-5893

Story at-a-glance Gardasil's ability to prevent cervical cancer is being questioned, with experts citing a lack of long-term studies proving reduced cancer rates While Gardasil targets specific HPV strains, concerns exist that it allows for the emergence of other harmful strains, thus canceling the vaccine's intended benefits Reports of severe side effects, including heart complications and even deaths, raise serious safety concerns, warranting caution The vaccine's aggressive marketing, despite the proven effectiveness of regular pap smears, suggests Gardasil's benefits have been exaggerated while risks have been downplayed Lawsuits alleging that Merck concealed risks and overstated Gardasil's efficacy are underway, casting doubt on the company's transparency and raising trust issues regarding pharmaceutical marketing

In this episode of the Scope of Things, host Deborah Borfitz delivers the latest on an AI-powered trial screening tool that outperforms research staff, a strategy report on ways to boost cancer vaccine work, the continued absence of pregnant women in clinical trials, a program bringing studies directly to people in rural Utah, and efforts to integrate clinical trials into routine patient care in medically underserved areas of Oklahoma. Wes Michael, founder and president of Rare Patient Voice, also joins in to discuss how his company is connecting people undertaking research studies with participants eager to share their insights—and getting paid to do so. News Roundup  AI clinical trial screening tool Research letter in JAMA  Strategy report on cancer vaccines Commentary in Cambridge Prisms: Precision Medicine  Exclusion of pregnant women from trials Article in American Journal of Obstetrics and Gynecology Bringing cancer care and trials to Utah's rural residents Press release on Huntsman Cancer Institute website Integrating clinical research into primary care News on OU Health Sciences website Guest Wes Michael, president and founder of Rare Patient Voice The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider's look at clinical research today.

Kidney cancer is one of the deadliest cancers, and a therapeutic vaccine shows promising results, offering new hope for those suffering with the disease. Dr. David Braun, a medical oncologist and researcher at Yale Cancer Center is here – he was the principal investigator on the kidney cancer vaccine study that published in the medical journal, Nature. Image Credit: Getty Images

More with Mayo Clinic's Dr. Bill Morice as he gets into the medical community's renewed hope for cancer vaccines to become a reality. Also - the very concerning and ongoing issue of cyberattacks on hospitals and healthcare. The Christopher Gabriel Program ----------------------------------------------------------- Please Like, Comment and Follow 'The Christopher Gabriel Program' on all platforms: The Christopher Gabriel Program is available on the KMJNOW app, Apple Podcasts, Spotify, YouTube or wherever else you listen to podcasts. --- The Christopher Gabriel Program | Website | Facebook | X | Instagram | --- Everything KMJ KMJNOW App | Podcasts | Facebook | X | Instagram See omnystudio.com/listener for privacy information.

A US judge temporarily blocks Trump's freeze on all federal grants and loans, Serbian Prime Minister Miloš Vučević resigns, Argentina moves to build a fence at the Bolivian border, the EU decides to ease sanctions on Syria, Israel continues its offensive in the West Bank, Trump announces four new executive orders to reshape the military, Microsoft reportedly considers buying TikTok, Several prosecutors who handled Trump's former criminal cases are dismissed, India and China agree to resume direct flights after a 5-year suspension, and the UK's GSK and Oxford reach a $62M deal to research cancer vaccines. Sources: www.verity.news

Physician & mRNA pioneer, Robert Malone, MD, joins Del to discuss tech giant Larry Ellison's recent promotion of employing mRNA vaccine technology to fight cancer. Get his expert view on his serious concerns about this technology that has already been proven to be dangerous and how Moderna has nearly gone bankrupt in the past after years of failed attempts of creating a vaccine for cancer. Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Dr. Anu Gaba, from Sanford Health, explains where the trials for a new breast cancer vaccine are at and what to expect. See omnystudio.com/listener for privacy information.

A lot has transpired since our last episode. We have a president again! And now Big Tech is telling us we can have a personalized AI-generated cancer vaccine within 48 hours based on the results of a blood test. Incredible! Is anyone else a bit skeptical of this nonsense?

Patrick Bet-David, Tom Ellsworth, Vincent Oshana, and Adam Sosnick cover Trump's clash with John Bolton, Larry Ellison's groundbreaking cancer vaccine, the Obama's rumored divorce, and Trump's war against woke culture. ----

With news about a possible Cancer Vaccine, Dan Mandis weighs in on this contraversial idea.See omnystudio.com/listener for privacy information.

Cancer is a disease that will affect 1 in 5 people in our lifetime, and it's estimated that around 20 million people worldwide will be diagnosed with some form of cancer in 2025.But how might a vaccine help in the treatment of cancer?Numerous trials began testing the viability of cancer vaccines in 2024, including one for Melanoma and another for Lung Cancer. With all the promise that these new cancer vaccine trials bring for cancer patients, we explore the different ways in which vaccines could work within the body, and how the time at which future vaccines are administered may vary according to the cancers they are targeting.This week on the Inquiry we're asking: Are we close to a cancer vaccine?Presenter: Tanya Beckett Producer: Matt Toulson Researcher: Katie Morgan Production Coordinator: Tim Fernley Editor: Tara McDermott Studio Director: Craig Boardman Contributors: Meredith McKean, director of Melanoma and Skin Cancer Research for Sarah Cannon Research Institute at Tennessee OncologySamra Turajlic, Chief Investigator of translational studies into melanoma and kidney cancer at the Francis Crick Institute and Professor at the Institute of Cancer Research Eduardo Vilar-Sanchez, professor in the department of Clinical Cancer Prevention at The University of Texas MD Anderson Cancer CenterPatrick Ott, Clinical Director at Melanoma Disease Center at the Dana-Farber Institute

Welcome to The Political Purple Breakdown, a feature of US RESIST NEWS, a nonprofit news service dedicated to providing truthful reporting in an age of disinformation. Join host Radell Lewis as we explore the intersection of U.S. domestic and international issues, offering insightful analysis on the stories shaping our world today. Learn more at www.usresistnews.org.

Welcome to The Political Purple Breakdown, a feature of US RESIST NEWS, a nonprofit news service dedicated to providing truthful reporting in an age of disinformation. Join host Radell Lewis as we explore the intersection of U.S. domestic and international issues, offering insightful analysis on the stories shaping our world today. Learn more at www.usresistnews.org.

Today we see that Feds Banned Drones of the New Jersey Area Air Space. Pastor Stan also shares 8 Tell-Tale signs the U.S. Government is Lying about the “Mysterious Drones”. In other news, Russia says it’s developed a Cancer Vaccine and will launch it for free. 00:00 – Intro 06:53 – Feds Ban Drones 09:09 – Eight Signs 13:03 – Cancer Free Vaccine 15:58 – Quantum Chip 19:15 – QFS Destroys Banking System 24:28 – Our Sponsors

Today we see that Feds Banned Drones of the New Jersey Area Air Space. Pastor Stan also shares 8 Tell-Tale signs the U.S. Government is Lying about the “Mysterious Drones”. In other news, Russia says it’s developed a Cancer Vaccine and will launch it for free. 00:00 – Intro 06:53 – Feds Ban Drones 09:09 – Eight Signs 13:03 – Cancer Free Vaccine 15:58 – Quantum Chip 19:15 – QFS Destroys Banking System 24:28 – Our Sponsors

Today we see that Feds Banned Drones of the New Jersey Area Air Space. Pastor Stan also shares 8 Tell-Tale signs the U.S. Government is Lying about the “Mysterious Drones”. In other news, Russia says it’s developed a Cancer Vaccine and will launch it for free. 00:00 – Intro 06:53 – Feds Ban Drones 09:09 – Eight Signs 13:03 – Cancer Free Vaccine 15:58 – Quantum Chip 19:15 – QFS Destroys Banking System 24:28 – Our Sponsors

Welcome to The Club! What country are Americans moving to the most? Also, does Russia really have a cancer vaccine?

Get your FREE copy of “Your A-Z Guide to Staying Cancer Free” here: https://bit.ly/azcancerfree New Research! New findings were released on the Triple Negative Breast Cancer Vaccine.   This is starting to sound promising.   Of course vaccines are quite controversial. But triple negative has such few treatment options so it's always nice to see more development.  More treatment options is always a good thing.  So if you are a triple negative breast cancer survivor or at high risk of developing breast cancer, this video is for you! So let me show you how it's done.   Join the Cancer Freedom Program Click HERE www.cancerfreedomprogram.com   #cancerfighter #cancersurvivor #breastcancer #breastcancersurvivors #cancerrecovery  #cancernutrition #mastectomy #tamoxifen #anastrozole #letrozole #exemestane    ***PS - Whenever you're ready, here are the 2 best ways I can help you… 1) “Your A-Z Guide to Staying Cancer Free” **FREE** Click HERE https://bit.ly/azcancerfree   2) Join the Cancer Freedom Program Click HERE www.cancerfreedomprogram.com   ***Let's Connect: Website: www.cancerfreedomprogram.com Instagram: https://www.instagram.com/dramymorris/ YouTube: https://www.youtube.com/channel/UCUt9... Facebook: https://www.facebook.com/dramycancer/

It's nearly thirty years since Kelly Macdonald made her acting debut as the sharp-witted 15 year old schoolgirl Diane in the classic film Trainspotting. Since then, the award winning actress has starred in critically acclaimed films like No Country for Old Men, Gosford Park, as well as Harry Potter franchise, and voiced the fearless Princess Merida in Pixar's Brave. Now, she's taking on a new role in the vampire comedy thriller, The Radleys.Scientists at the University of Oxford are creating OvarianVax, a vaccine which teaches the immune system to recognise and attack the earliest stages of ovarian cancer. The hope is that the jab could be given to women preventatively on the NHS with the aim of eliminating the disease. We talk to Professor Ahmed Ahmed from the university of Oxford, who is leading the research into the jab, and Cary Wakefield CEO of Ovarian Cancer Action, to find out when exactly we might see this becoming available.Hundreds of women have recently been protesting in Turkish cities after the killing of two young women in Istanbul – followed by protests every day for a week across the country, notably on university campuses. Recently the "We Will Stop Femicide Platform" reported that in Turkey, 34 women were murdered by men and 20 more died under suspicious circumstances in September alone. We hear from Elif Shafak - award-winning British-Turkish novelist and storyteller, and Times Turkey Correspondent Hannah Lucinda Smith.Presenter: Nuala McGovern Producer: Laura Northedge

A closer look at unexpected trends in dating as more young people are ditching the dating apps to find love in person. Also, inside the push to create a safe and effective vaccine for breast cancer. Plus, in honor of Hispanic Heritage Month, pastry chef Paola Velez shares a delicious coquito cheesecake recipe.

In this episode of the SHE MD podcast, Kristen Dahlgren and Dr. Kiran Dhillon join us to discuss groundbreaking vaccines being developed to prevent and treat breast cancer. Did you know that one in eight women will be diagnosed with breast cancer in their lifetime? The first vaccines being developed are targeting the most aggressive forms of the disease, offering hope to those who need it now. Kristen and Dr. Dhillon share their involvement with the Cancer Vaccine Coalition and highlight the progress in targeting aggressive cancers such as ductal, lobular, and inflammatory breast cancers. They explain the challenges of funding these life-saving vaccines, the importance of early detection, and the role of personalized medicine. Tune in to learn about current clinical trials, how vaccines stop cancer recurrence, and how listeners can support this vital research. For more resources, visit our website: SheMDpodcast.comFollow us across social media: @SheMDpodcastSponsors: Knowing your family's history of cancer is the first step to understanding your own cancer risk and may qualify you for the MyRisk Hereditary Cancer Test with RiskScore hereditary cancer test. It's easy, accurate and covered by most insurers. Learn more at GetMyRisk.com, https://myriad.ws/getmyrisk If you want to take ownership of your health, it starts with AG1. Try AG1 and get a FREE 1-year supply of Vitamin D3K2 AND 5 free AG1 Travel Packs with your first purchase at drinkAG1.com/shemd.Get 10% off your first order sitewide with code SHEMD at OSEAMalibu.comRedefine learning with play! Get 50% off your first month on ANY crate line at KIWICO.com, promo code SHEMD. IN THIS EPISODE:[00:00] Kristen and Dr. Dhillon explain how they got involved in the Cancer Vaccine Coalition.[05:06] The different types of cancers and vaccines developed to target them; examples are ductal, lobular and inflammatory[09:15] There are vaccines available; however, Kristen says there isn't the funding needed and discussion of a study that started ten years ago and timelines for making the vaccines available to the public[18:38] Kristen discusses barriers to working on vaccines, the composition of the Cancer Vaccine Coalition and personalized vaccines, and Dr. A tells about her journey with breast cancer[25:28] Why younger women and men are getting cancer, how does the inflammation factor weigh in[38:35] Vaccines and trials for BRCA-positive patients[47:24] Dr. Dhillon explains how vaccines work, the current active studies and getting scientists together from all over the world to collaborate[53:31] Results of the breast cancer study, expediting the studies and the number of clinical trials going on now and how much money it would take to completely fund those trialsKEY TAKEAWAYS: Schedule Regular Screenings: Encourage regular screenings for those you know. Breast cancer can affect anyone, regardless of family history.Support Cancer Vaccine Research: Donate to the Cancer Vaccine Coalition to help fund the development of life-saving breast cancer vaccines. The coalition does groundbreaking work in targeting aggressive breast cancers.Learn About Clinical Trials: If you or someone you know has breast cancer, explore current vaccine trials, especially if BRCA-positive. Kristen and Dr. Kiran discuss how listeners can get involved in these studies and help advance the development of vaccines.Stay Informed: Stay up to date on advancements in vaccines tailored to individual cancer profiles. This emerging field holds promise for treating cancers more effectively, and understanding your specific risks can lead to better treatment outcomes.Advocate for Increased Funding: Spread awareness about the need for more funding to make breast cancer vaccines widely available. Talk to your networks, share information from the episode, and encourage others to contribute to this critical cause.RESOURCES:Today Show - Kristen DahlgrenCancer Vaccine Coalition DONATE - WebsiteClinical Trials - GovCancer Vaccine Institute Trials- WebsiteNewsletter Sign UpCONNECT WITH SHE MD: Mary Alice Haney - InstagramDr. Thaïs Aliabadi - InstagramSheMD Podcast - InstagramSHEMD - YouTubeSHEMD - PodcastQUOTES:“We're trying to find these proteins pushing these cancer cells to grow and metastasize, and then lurk around and come back years later and get the immune system to see those as dangerous, just like you might see the COVID-19 virus or something like that. Then we go after those.” -Dr. Kiran Dhillon“It's incredible to me that I, a journalist, with not oodles of money like the federal government, must try and put together the funding to support this incredible research….we certainly have hospitals and academics that are willing to work together along with pharmaceutical companies and get these into widespread trials quickly because we're losing thousands of women and men every year. So we can say well, we will have these vaccines in 20 to 30 years, or we can create a movement where we say this is not acceptable and we fund the research, and we get this moving to save lives.” -Kristen Dahlgren See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Recently, doctors announced some extremely encouraging news about a jab for people with advanced forms of several types of malignancy, including melanoma, lung cancer and other solid organ tumours. The vaccine is called mRNA-4359 and has been developed by the pharmaceutical company Moderna, of Covid vaccine fame. The trials have been conducted here in the UK, and we'll hear from the man running the study. Also, the success of the HPV vaccine in preventing cervical cancer, and how a Lynch syndrome vaccine could prevent a variety of malginancies... Like this podcast? Please help us by supporting the Naked Scientists

Trials of a cancer 'vaccine' have begun and presenter James meets Steve, one of the first patients to trial the new treatment, Steve remembers his shock at being diagnosed with colorectal cancer in his 40s and tells the story of how he became involved in this pioneering research into tackling cancer.The vaccine is based on the same mRNA technology as the Pfizer-BioNTech COVID-19 vaccine and James heads to the University of Cambridge to find out how the early work into cancer vaccines became the foundation for the rapid rollout of the covid vaccine. In the lab, molecular biologist Dr Anne Willis and immunologist Dr James Thaventhiran explain how the vaccine is personalised to target the unique make-up of an individual patients' cancer cells, and how if the trials are successful they could open the door to mRNA treatments being used to treat a wide range of diseases.Also, Imperial College London cyber security researcher Dr Saira Ghafur joins James in the studio to explain why healthcare is a growing target for cyber attackers and how we can prepare for the next one because, as Saira says, it really is a case of "when" not "if".Presented by James Gallagher Produced by Tom Bonnett with Hannah Robins Assistant Producer: Katie Tomsett Editor: Holly Squire

We'd love to hear from you! Send us a text message.In this episode of "Discover Daily," we delve into the arrest of Telegram founder Pavel Durov in France, exploring the allegations of insufficient content moderation and the potential implications for free speech platforms worldwide. We examine the charges against Durov and Telegram, the alleged violations of the Digital Services Act, and the company's response to these accusations. We then shift our focus to Meta's decision to cancel its high-end mixed reality headset project, codenamed "La Jolla," which was intended to compete with Apple's Vision Pro. We discuss the reasons behind this cancellation, including high production costs and the lukewarm market reception of similar devices, while exploring Meta's ongoing commitment to developing more affordable mixed reality devices.Finally, we explore the groundbreaking lung cancer vaccine trial that has begun across seven countries. We examine how BioNTech's mRNA-based vaccine BNT116 works, its potential to revolutionize cancer treatment, and the preliminary results from early trials. We discuss the vaccine's targeted approach, its differences from traditional chemotherapy, and the implications for the future of cancer immunotherapy.From Perplexity's Discover Feed:https://www.perplexity.ai/page/telegram-founder-arrested-in-f-LfP78tciSl.8w9ezhGfjCAhttps://www.perplexity.ai/page/meta-cancels-vision-pro-compet-0YdufFfWSuOpvewDU4W1.Ahttps://www.perplexity.ai/page/first-lung-cancer-vaccine-tria-zGag7w53Qq.FiPhAm2.wCwPerplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you're interested in. Take the world's knowledge with you anywhere. Available on iOS and Android Join our growing Discord community for the latest updates and exclusive content. Follow us on: Instagram Threads X (Twitter) YouTube Linkedin

Researchers say the Wet Bulb Globe Temperature is a better indicator of heat stress. Also, cancer is the leading cause of death in dogs. A new vaccine has increased survival rates in clinical trials, offering hope for dogs and humans.Yes, It's Hot. But How Hot?Much of the country has been enduring a heat wave this week, with millions sweating from Maine to the Midwest. But describing exactly how hot it is—and when temperatures become hazardous—can be challenging. Beyond the basic temperature, there's the heat index, invented in 1978, which incorporates humidity measurements and is supposed to give a better indication of how a person might feel outside. Some health researchers are calling for more attention to a different type of temperature measurement known as the wet bulb globe temperature. It tracks temperature, humidity, and sunlight, and improves upon the heat index standard.Umair Irfan, senior correspondent at Vox, joins SciFri's Kathleen Davis to talk about measuring temperatures and protecting yourself from extreme heat. Plus, they discuss other stories from the week in science, including advances in tornado prediction, a delay in a return flight from the International Space Station, and a newly-described horned dinosaur that once roamed the US.A Canine Cancer Vaccine Shows Promising ResultsDogs are by far the most popular pet in the United States: 62 million households have at least one. They are humans' best friends, after all. Sadly, cancer is the leading cause of death in domestic dogs. And when a pet gets sick, it can be devastating for the entire family.Lucky for dogs (and their people), there may soon be a breakthrough in treating canine cancer: a vaccine that can slow and even stop the spread of tumors. Clinical trial results are quite promising so far, increasing 12-month survival rates in dogs with some cancers from 35% to 60%. The research team also reports that in many dogs the vaccine shrinks tumors.Joining guest host Kathleen Davis to talk about this novel therapy is Dr. Mark Mamula, professor of medicine at the Yale School of Medicine in New Haven, Connecticut. Mamula discusses this important breakthrough, and possible future applications for human cancer therapies.Transcripts for each segment will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

The news to know for Tuesday, June 4, 2024! We'll tell you about President Biden's action that might close the southern border immediately. Also, there was another dramatic hearing on Capitol Hill, this time involving Dr. Anthony Fauci, and a heatwave is set to impact millions of Americans this week. Plus, there is new promising data about a melanoma vaccine; a new policy allows x-rated content on X, and gymnast Simone Biles broke another record. Those stories and more news to know in about 10 minutes! See sources: https://www.theNewsWorthy.com/shownotes Sign-up for our bonus weekly email: https://www.theNewsWorthy.com/email Get The NewsWorthy merch here: https://www.theNewsWorthy.com/merch Become an INSIDER and get ad-free episodes: https://www.theNewsWorthy.com/insider Episode Sponsors: Get a special deal with Hiya for their best selling children's vitamin: receive 50% off your first order at hiyahealth.com/NEWSWORTHY Get 20% OFF Honeylove by going to honeylove.com/newsworthy #honeylovepod To advertise on our podcast, please reach out to libsynads@libsyn.com    

Dr. Vinod Balachandran explains how he and his colleagues successfully treated pancreatic cancer with bespoke mRNA vaccines. Science journalist Charles Graeber says this could be cancer's “penicillin moment.” This episode was produced by Avishay Artsy, edited by Matt Collette, fact-checked by Laura Bullard, engineered by Michael Raphael, and hosted by Sean Rameswaram. Transcript at vox.com/todayexplained  Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts Learn more about your ad choices. Visit podcastchoices.com/adchoices